Nuwellis, Inc.

NUWE - Financial Snapshot

Healthcare sector | Medical Devices industry

View on:
Ranks:

Metrics for NUWE

Price $3.89
Shares Outstanding 0.9M
All-Time Low $1.71
52-Week Low $1.71

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share $3.47
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $4.34
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Shares Outstanding Ave Change (Annual) 1036.2%
Shares Δ YoY 2594.49%

Income Metrics

Max Earning Power / Share $7.09
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $4.94
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 5.99%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 02-03-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 2-1-2026
Last Dividend Date 10-18-20
Income indicators Value Date
EBITDA Positive Yes 2-1-2026
Net Income Positive Yes 2-1-2026
Avg CA Burn (Annual %) -25.04% 2-1-2026
Avg CA Burn (Quarterly %) 13.33% 2-1-2026

Shares Outstanding Changes

Date Shares Outstanding Delta
2025-08-22 902,665 +375,507
2025-08-19 527,158 -6,427,482

Short Interest Changes

Latest short interest: 5,056 shares (0.58% of float) | Days to cover: 0.06

Date Short Interest Delta Δ %
2026-02-03 5,056 shares +0 +0.00%
2026-02-02 5,056 shares +0 +0.00%
2026-01-30 5,056 shares None —

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
2026-02-03 357,219 902,665 39.57% $3.89
2026-02-02 599,878 902,665 66.46% $3.85
2026-01-30 523,619 902,665 58.01% $3.77
2026-01-29 1,651,065 902,665 182.91% $4.19
2026-01-28 2,422,313 902,665 268.35% $3.86
2026-01-27 112,785,805 902,665 12494.76% $3.83
2026-01-26 5,417,167 902,665 600.13% $2.15
2026-01-16 456,817 902,665 50.61% $1.90
2026-01-15 1,347,571 902,665 149.29% $2.37

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.